Advertisement

Oral Corticosteroid Use for Loss of Flexion After Primary Anterior Cruciate Ligament Reconstruction

      Purpose: Postoperative loss of motion after anterior cruciate ligament (ACL) reconstruction can lead to suboptimal outcomes. Short-term low-dose oral corticosteroids are an option for nonsurgical management of this condition. The purpose of this study is to retrospectively review a series of patients treated with a single Medrol Dosepak (MDP) (Pfizer, New York, NY) in the early postoperative period for the treatment of loss of flexion, focusing on range of motion, objective instrumented stability measurements, and complications. Methods: From September 1, 2003, through January 1, 2007, 28 (11%) of 252 patients who underwent primary ACL reconstruction were treated with an MDP at a mean of 6.1 weeks postoperatively (range, 4 to 12 weeks; SD, 1.4 weeks) for early postoperative loss of motion. Of these 28 patients, 4 were not included because of unavailable clinical records. One patient who underwent combined ACL and posterior cruciate ligament reconstruction with medial collateral ligament repair was excluded from the analysis. Range-of-motion and KT-1000 (MEDmetric, San Diego, CA) measurements were independently recorded by a single examiner preoperatively, at 6 weeks postoperatively, and again at final follow-up evaluation at a mean of 10.4 months (range, 4 to 24 months; SD, 4.3 months). Results: The mean flexion deficit compared with the normal, contralateral knee at the time of treatment with an MDP was 31.3° (range, −2° to 55°; SD, 14.8°). Patients treated with an MDP showed a significant improvement in flexion deficit (mean, 29.2°; range, 0° to 60°; SD, 17.1°) after MDP treatment (P < .001). KT-1000 side-to-side differences at final examination were 2 mm or less in 22 of 23 patients (mean, 1 mm; range, 0 to 4 mm; SD, 1 mm). Of the 23 patients treated with an MDP, 5 (22%) were considered failures because they required surgical intervention for persistent loss of motion, resulting in a reoperation rate for loss of motion after primary ACL reconstruction of 2.0% (5/252). There were no documented complications of MDP treatment. Specifically, no patients treated with an MDP had a postoperative infection develop. Conclusions: The use of oral corticosteroids, in the form of an MDP, was associated with a successful return of normal range of motion in 78% of patients with early postsurgical loss of flexion and near-normal extension after primary ACL reconstruction without any associated complications or decrease in objective instrumented stability measurements. Level of Evidence: Level IV, therapeutic case series.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dandy D.J.
        • Edwards D.J.
        Problems in regaining full extension of the knee after anterior cruciate ligament reconstruction: does arthrofibrosis exist?.
        Knee Surg Sports Traumatol Arthrosc. 1994; 2: 76-79
        • Magit D.
        • Wolff A.
        • Sutton K.
        • Medvecky M.J.
        Arthrofibrosis of the knee.
        J Am Acad Ortho Surg. 2007; 15: 682-694
        • Shelbourne K.D.
        • Nitz P.
        Accelerated rehabilitation after anterior cruciate ligament reconstruction.
        Am J Sports Med. 1990; 18: 292-299
        • Millett P.J.
        • Wickiewicz T.L.
        • Warren R.F.
        Motion loss after ligament injuries to the knee.
        Am J Sports Med. 2001; 29: 664-675
        • Millett P.J.
        • Wickiewicz T.L.
        • Warren R.F.
        Motion loss after ligament injuries to the knee.
        Am J Sports Med. 2001; 29: 822-828
        • Paulos L.E.
        • Rosenberg T.D.
        • Drawbert J.
        • Manning J.
        • Abbott P.
        Infrapatellar contracture syndrome.
        Am J Sports Med. 1987; 15: 331-341
        • Cosgarea A.J.
        • Sebastianelli W.J.
        • DeHaven K.E.
        Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft.
        Am J Sports Med. 1995; 23: 87-92
        • Shelbourne K.D.
        • Patel D.V.
        • Martini D.J.
        Classification and management of arthrofibrosis of the knee after anterior cruciate ligament reconstruction.
        Am J Sports Med. 1996; 24: 857-862
        • Noyes F.R.
        • Berrios-Torres S.
        • Barber-Westin S.D.
        • Heckmann T.P.
        Prevention of permanent arthrofibrosis after anterior cruciate ligament reconstruction alone or combined with associated procedures: A prospective study in 443 knees.
        Knee Surg Sports Traumatol Arthrosc. 2000; 8: 196-206
        • Jackson D.W.
        • Schaefer R.K.
        Cyclops syndrome: Loss of extension following intra-articular anterior cruciate ligament reconstruction.
        Arthroscopy. 1990; 6: 171-178
        • Shelbourne K.D.
        • Patel D.V.
        Treatment of limited motion after anterior cruciate ligament reconstruction.
        Knee Surg Sports Traumatol Arthrosc. 1999; 7: 85-92
        • Harmon K.G.
        • Hawley C.
        Physician prescribing patterns of oral corticosteroids for musculoskeletal injuries.
        J Am Board Fam Pract. 2003; 16: 209-212
        • Andrews J.R.
        Diagnosis and treatment of chronic painful shoulder: Review of nonsurgical interventions.
        Arthroscopy. 2005; 21: 333-347
        • Cosgarea A.J.
        • DeHaven K.E.
        • Lovelock J.E.
        The surgical treatment of arthrofibrosis of the knee.
        Am J Sports Med. 1994; 22: 184-191
        • McKee M.D.
        • Waddell J.P.
        • Kudo P.A.
        • Schemitsch E.H.
        • Richards R.R.
        Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: A report of 15 cases.
        CMAJ. 2001; 164: 205-206
        • Gloystein D.M.
        • Gillespie M.J.
        • Schenck R.C.J.
        The effects of medications in sports injuries.
        in: DeLee J.C. Drez D. Miller M.D. DeLee and Drez's orthopaedic sports medicine: Principles and practice. Ed 2. Saunders, Philadelphia2003: 121-134
        • Haynes R.C.
        Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones.
        in: Gilman A.G. The Pharmacological Basis of Therapeutics. McGraw-Hill, New York1993: 1431-1462
        • Langer P.
        • Fadale P.
        • Hulstyn M.
        • Fleming B.
        • Brady M.
        Survey of orthopaedic and sports medicine physicians regarding use of Medrol Dosepak for sports injuries.
        Arthroscopy. 2006; 22: 1263.e1-1269.e2
        • Nichols A.W.
        Complications associated with the use of corticosteroids in the treatment of athletic injuries.
        Clin J Sport Med. 2005; 15: 370-375
        • Buchbinder R.
        • Hoving J.L.
        • Green S.
        • Hall S.
        • Forbes A.
        • Nash P.
        Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): A randomised, double blind, placebo controlled trial.
        Ann Rheum Dis. 2004; 63: 1460-1469
        • O'Brien T.J.
        • Mack G.R.
        Multifocal osteonecrosis after short-term high-dose corticosteroid therapy.
        Clin Orthop Relat Res. 1992; 279: 176-179
        • Da Silva J.A.
        • Jacobs J.W.
        • Kirwan J.R.
        • et al.
        Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data.
        Ann Rheum Dis. 2006; 65: 285-293
        • Tucker A.M.
        • Martins D.A.
        • Yorio M.A.
        Oral corticosteroids and treatment of National Football League players: A survey of team physicians.
        Curr Opin Orthop. 2004; 15: 108-112
        • Bach Jr, B.R.
        • Levy M.E.
        • Bojchuk J.
        • Tradonsky S.
        • Bush-Joseph C.A.
        • Khan N.H.
        Single-incision endoscopic anterior cruciate ligament reconstruction using patellar tendon autograft.
        Am J Sports Med. 1998; 26: 30-40